President Trump says he will slap new levies on pharmaceuticals and big trucks ...

Tariffs Overview - The new tariffs include a 25% levy on heavy trucks and 100% tariffs on pharmaceuticals, set to take effect next Wednesday [2][4][9] - The tariffs are part of ongoing investigations by the Commerce Department under the Section 232 rule, which may be more difficult to legally challenge compared to previous tariffs [3][4] Pharmaceutical Sector Impact - The implementation of the 100% tariff on pharmaceuticals could increase the average tariff rate by 3.3 percentage points [5] - Major pharmaceutical companies like AstraZeneca, Johnson & Johnson, and Merck have been preparing for potential tariffs this year, with some pledging billions in US manufacturing investments [6][7] - There are uncertainties regarding whether companies can be exempted from tariffs if they are constructing US manufacturing plants, and how these new tariffs will interact with existing agreements, such as the 15% tariffs agreed upon with the EU [8]

How do we fix this. It looks like pharmaceutical stocks are going to be under a little bit of pressure this morning, but European equities broadly look like they're on the front foot. Absolutely.Futures are up across the board actually now. And that's perhaps surprising because we've had these big tariff announcements. If you look back to April, when we had announcements like this, it weighed on equities very heavily.But I think there are two factors happening here. One is that this has happened before. We' ...

AND AFRICA. " OUR TOP STORIES THIS MORNING. THROWING IN THE KITCHEN SINK. U.S. PRESIDENT DONALD TRUMP ANNOUNCES A 100% LEVY ON PHARMACEUTICALS, AS WELL AS HEAVY TRUCKS, KITCHEN CABINETS, AND BATHROOM VANITIES. TRUMP SIGNS AND OFFER FOR TIKTOK. AND A WHITE HOUSE MEETING. TRUMP URGES TYPE OF ERDOGAN TO HALT PURCHASES OF RUSSIAN OIL WHILE HOLDING THE DOOR OPEN FOR TURKEY OBTAINING FIGHTER JETS, SAYING HE WANTS SOMETHING IN RETURN. IT HAS JUST GONE 8:00 A.M. DEFINITELY TRUMP WANT SOMETHING IN RETURN IN RELATION ...

European stocks gained as investors were unmoved by President Donald Trump’s threats to slap tariffs on patented drugs https://t.co/J3VsqFol7e ...

Asian Pharmaceutical Stocks Slump As Trump Announces 100% Tariffs On Patented Drugshttps://t.co/umLkYIwPlC https://t.co/Ml1TrIl5xU ...

Core Viewpoint - The announcement of new tariffs by Trump, including a 100% levy on drugs from companies not building plants in the U.S., has led to a decline in the value of the dollar [1] Group 1 - The new tariffs specifically target pharmaceutical companies that do not invest in U.S. manufacturing [1] - The 100% levy on drugs is a significant increase that could impact pricing and availability in the market [1] - The announcement has immediate effects on currency valuation, as evidenced by the dollar turning lower [1]

Representative imageCompanies without existing US manufacturing plants could face the full impact, triggering declines across major drugmakers in South Korea, Japan, and Hong Kong.In South Korea, Samsung Biologics fell 1.6%, while SK Biopharmaceuticals slid 2.6%. Celltrion, which recently acquired ImClone Systems from Eli Lilly in the United States for $330 million, rose 1.3% after recouping earlier losses.In Japan, Sumitomo Pharma tumbled 4.3%, Otsuka Holdings dropped 3.5%, and Daiichi Sankyo lost 1.6%. Ta ...

Core Insights - RH Inc. shares dropped 3.39% to $204.14 in after-hours trading following President Trump's tariff announcement targeting home furnishings [1] - The U.S. will impose a 30% tariff on upholstered furniture and a 50% tariff on bathroom vanities, attributed to a "massive influx" of foreign products [2] - All tariff measures will take effect on October 1, including a 25% tariff on heavy-duty trucks and a 50% tariff on kitchen cabinets [3] Stock Performance - RH closed at $211.30 on Thursday, down 0.62% for the regular session, and has fallen 46.31% year-to-date with a 52-week range of $123.03-$457.26 [3] - The company's market capitalization is $3.96 billion with a price to earnings ratio of 39.30 [3] - RH reached a peak of $454.52 on January 2, showing a 53.51% decline from that peak [4] Market Sentiment - Benzinga's Edge Stock Rankings indicate that RH is experiencing medium-term upward movement despite recent declines [4]

Group 1 - Asian share markets experienced a significant selloff, particularly in drugmakers and furniture makers, following the announcement of new tariffs by U.S. President Donald Trump [1][5] - The new tariffs include a 100% duty on branded drugs and a 25% tariff on heavy-duty trucks, effective from October 1, which could impact global drugmakers and manufacturers [1][4] - Companies like Paccar-owned Peterbilt and Kenworth, as well as Daimler Truck-owned Freightliner, may benefit from the tariffs on heavy-duty trucks [4] Group 2 - The Trump administration's trade deals with Japan, the EU, and the UK include provisions that cap tariffs for specific products, which may limit the impact of the new tariffs on certain sectors [3] - Global drugmakers are proactively increasing their U.S. manufacturing capacity and domestic inventory in response to the new tariffs [3] - The market is currently pricing in approximately 39 basis points of easing by December, reflecting a shift in expectations regarding U.S. interest rate cuts due to tariff-related inflation concerns [6]